Influence of Tea Consumption on the Development of Second Esophageal Neoplasm in Patients with Head and Neck Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2019 Mar 22

PMID 30893904

Citations 5

Authors

Yao-Kuang Wang

Wei-Chung Chen

Ying-Ho Lai

Yi-Hsun Chen

Ming-Tsang Wu

Chie-Tong Kuo

Yen-Yun Wang

Shyng-Shiou F Yuan

Yu-Peng Liu

I-Chen Wu

Affiliations

Soon will be listed here.

Abstract

Alcohol is an important risk factor for the development of second esophageal squamous-cell carcinoma (ESCC) in head and neck squamous-cell carcinoma (HNSCC) patients. However, the influence of tea consumption is uncertain. We prospectively performed endoscopic screening in incident HNSCC patients to identify synchronous esophageal neoplasm. In total, 987 patients enrolled between October 2008 and December 2017 and were analyzed. In vitro studies were conducted to investigate the effect of epigallocatechin gallate (EGCG) on the betel alkaloid, arecoline-stimulated carcinogenesis in two ESCC cell lines. There were 151 patients (15.3%) diagnosed to have synchronous esophageal neoplasm, including 88 low-grade dysplasia, 30 high-grade dysplasia and 33 squamous-cell carcinoma (SCC). Tea consumption was associated with a significantly lower risk of having esophageal high-grade dysplasia or SCC in HNSCC patients, especially those who were betel nut chewers, alcohol drinkers or cigarette smokers (all adjusted odds ratio were 0.5; -values: 0.045, 0.045 and 0.049 respectively). In vitro studies indicated that EGCG suppressed arecoline-induced ESCC cell proliferation and colony formation through the inhibition of the Akt and ERK1/2 pathway in a reactive oxygen species-independent manner. In conclusion, tea consumption may protect against the development of second esophageal neoplasms among HNSCC patients, especially those who regularly consume betel nuts, alcohol and cigarettes.

Citing Articles

Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives.

Han S, Bommireddy R, Kim P, Selvaraj P, Shin D Cancer Prev Res (Phila). 2024; 17(10):443-455.

PMID: 38978394 PMC: 11844769. DOI: 10.1158/1940-6207.CAPR-24-0093.

Factors associated with the development of second primary tumours in head and neck cancer patients.

Salcedo-Bellido I, Requena P, Mateos R, Ortega-Rico C, Olmedo-Requena R, Lozano-Lorca M Eur J Cancer Care (Engl). 2022; 31(6):e13699.

PMID: 36117311 PMC: 9787413. DOI: 10.1111/ecc.13699.

A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma.

Huang R, Dai Q, Yang R, Duan Y, Zhao Q, Haybaeck J Front Oncol. 2022; 12:817916.

PMID: 35574327 PMC: 9096244. DOI: 10.3389/fonc.2022.817916.

Characteristics of esophageal cancer in patients with head and neck squamous cell carcinoma.

Wang L, Pang W, Zhou K, Li L, Wang F, Cao W Transl Cancer Res. 2022; 10(5):1954-1961.

PMID: 35116518 PMC: 8799255. DOI: 10.21037/tcr-20-2880.

Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer.

Man G, Wang J, Song Y, Wong J, Zhao Y, Lau T BMC Cancer. 2020; 20(1):964.

PMID: 33023525 PMC: 7539473. DOI: 10.1186/s12885-020-07455-3.

References

Yang Y, Chang K, Chen C, Chiu T . Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor. Chin J Physiol. 2000; 43(1):23-8. View

Ghelardini C, Galeotti N, Lelli C, Bartolini A . M1 receptor activation is a requirement for arecoline analgesia. Farmaco. 2001; 56(5-7):383-5. DOI: 10.1016/s0014-827x(01)01091-6. View

Sah J, Balasubramanian S, Eckert R, Rorke E . Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem. 2004; 279(13):12755-62. DOI: 10.1074/jbc.M312333200. View

Xie D, Chen L, Liu C, Zhang C, Liu K, Wang P . Arecoline excites the colonic smooth muscle motility via M3 receptor in rabbits. Chin J Physiol. 2004; 47(2):89-94. View

Cui Q, Fogle E, Almazan G . Muscarinic acetylcholine receptors mediate oligodendrocyte progenitor survival through Src-like tyrosine kinases and PI3K/Akt pathways. Neurochem Int. 2006; 48(5):383-93. DOI: 10.1016/j.neuint.2005.11.014. View

Yang C, Lambert J, Ju J, Lu G, Sang S . Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol Appl Pharmacol. 2007; 224(3):265-73. PMC: 2698225. DOI: 10.1016/j.taap.2006.11.024. View

Chuang S, Scelo G, Tonita J, Tamaro S, Jonasson J, Kliewer E . Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer. 2008; 123(10):2390-6. DOI: 10.1002/ijc.23798. View

Hsu N, Yeh K, Chiang I, Pai L, Chen C, Ho H . Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis. Dis Esophagus. 2009; 21(5):402-8. DOI: 10.1111/j.1442-2050.2007.00775.x. View

Lagiou P, Talamini R, Samoli E, Lagiou A, Ahrens W, Pohlabeln H . Diet and upper-aerodigestive tract cancer in Europe: the ARCAGE study. Int J Cancer. 2009; 124(11):2671-6. DOI: 10.1002/ijc.24246. View

10.

Chen Y, Lee C, Wu I, Liu J, Wu D, Lee J . Food intake and the occurrence of squamous cell carcinoma in different sections of the esophagus in Taiwanese men. Nutrition. 2009; 25(7-8):753-61. DOI: 10.1016/j.nut.2009.02.002. View

11.

Yang C, Wang X, Lu G, Picinich S . Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 2009; 9(6):429-39. PMC: 2829848. DOI: 10.1038/nrc2641. View

12.

Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V . A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009; 10(11):1033-4. DOI: 10.1016/s1470-2045(09)70326-2. View

13.

Chiu C, Chen B, Hour T, Chiang W, Wu Y, Chen C . Betel quid extract promotes oral cancer cell migration by activating a muscarinic M4 receptor-mediated signaling cascade involving SFKs and ERK1/2. Biochem Biophys Res Commun. 2010; 399(1):60-5. DOI: 10.1016/j.bbrc.2010.07.042. View

14.

Van Aller G, Carson J, Tang W, Peng H, Zhao L, Copeland R . Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochem Biophys Res Commun. 2011; 406(2):194-9. DOI: 10.1016/j.bbrc.2011.02.010. View

15.

Oliva J, Bardag-Gorce F, Tillman B, French S . Protective effect of quercetin, EGCG, catechin and betaine against oxidative stress induced by ethanol in vitro. Exp Mol Pathol. 2011; 90(3):295-9. PMC: 3113678. DOI: 10.1016/j.yexmp.2011.02.006. View

16.

Tu S, Ku C, Ho C, Chen C, Huang C, Lee C . Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced α9-nicotinic acetylcholine receptor upregulation in human breast cancer cells. Mol Nutr Food Res. 2011; 55(3):455-66. DOI: 10.1002/mnfr.201000254. View

17.

Yang C, Wang H, Li G, Yang Z, Guan F, Jin H . Cancer prevention by tea: Evidence from laboratory studies. Pharmacol Res. 2011; 64(2):113-22. DOI: 10.1016/j.phrs.2011.03.001. View

18.

Yen C, Lin M, Liu S, Chiang W, Hsieh W, Cheng Y . Arecoline-mediated inhibition of AMP-activated protein kinase through reactive oxygen species is required for apoptosis induction. Oral Oncol. 2011; 47(5):345-51. DOI: 10.1016/j.oraloncology.2011.02.014. View

19.

Smedlund K, Tano J, Margiotta J, Vazquez G . Evidence for operation of nicotinic and muscarinic acetylcholine receptor-dependent survival pathways in human coronary artery endothelial cells. J Cell Biochem. 2011; 112(8):1978-84. DOI: 10.1002/jcb.23169. View

20.

Hung T, Huang L, Su S, Hsieh B, Cheng H, Hu Y . Hemeoxygenase-1 expression in response to arecoline-induced oxidative stress in human umbilical vein endothelial cells. Int J Cardiol. 2011; 151(2):187-94. DOI: 10.1016/j.ijcard.2010.05.015. View